 |
Thalidomide |
|---|---|
| Trade Name | |
| Orphan Indication | Treatment and maintenance of reactional lepromatous leprosy |
| USA Market Approval | USA |
| USA Designation Date | 1988-11-15 00:00:00 |
| Sponsor | Pediatric Pharmaceuticals, Inc.;718 Bradford Avenue;Westfield, New Jersey, 07090 |
